Article
Integrating multi-omics biomarkers and postprandial metabolism to develop personalized treatment for anorexia nervosa.
Prostaglandins & other lipid mediators - 1 Sept 2017
Shih Pei-An Betty
Abstract excerpt
BACKGROUND: Anorexia Nervosa (AN) is a serious mental illness characterized by emaciation, an intense fear of gaining weight despite being underweight, and distorted body image. Few treatments reverse the core symptoms in AN such as profound aversion to food and food avoidance. Consequently, AN has a chronic and relapsing course and the highest mortality rate of any psychiatric illness. A more complete...
Topics
Join the communities discussing this publication.
